Nanobiotix Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Short-Term Investments	52.75	49.74	75.28	41.39	83.92
Cash Growth	6.06%	-33.93%	81.90%	-50.68%	-29.57%
Accounts Receivable	2.14	2.98	0.91	0.1	-
Other Current Assets	7.86	8.75	11.15	10.87	9.14
Total Current Assets	62.75	61.47	87.34	52.36	93.06
Net Property, Plant & Equipment	4.57	5.54	6.25	7.12	8.19
Other Intangible Assets	0.01	0.01	0.01	0	0
Other Long-Term Assets	0.43	0.41	0.3	0.29	0.52
Total Assets	67.76	67.42	93.9	59.77	101.77
Accounts Payable	9.12	20.04	18.24	9.62	6.48
Current Portion of Long-Term Debt	4.31	4.92	5.02	4.56	8.2
Unearned Revenue	36.22	18.16	18.23	16.57	16.77
Other Current Liabilities	7.86	15.82	8.39	7.18	5.39
Total Current Liabilities	57.51	58.94	49.87	37.94	36.85
Long-Term Debt	91.01	45.98	45.54	48.61	37.82
Other Long-Term Liabilities	3.73	28.21	0.32	0.27	0.32
Total Long-Term Liabilities	94.74	74.19	45.87	48.88	38.13
Total Liabilities	152.24	133.12	95.74	86.81	74.98
Common Stock	1.45	1.42	1.41	1.05	1.05
Treasury Stock	-0.23	-0.23	-0.23	-0.23	-0.2
Additional Paid-in Capital	314.4	312.74	312.74	255.76	255.77
Accumulated Other Comprehensive Income	0.69	0.71	0.74	0.7	0.64
Retained Earnings	-400.8	-380.35	-316.51	-284.32	-230.46
Shareholders' Equity	-84.48	-65.7	-1.84	-27.05	26.79
Total Liabilities & Equity	67.76	67.42	93.9	59.77	101.77
Total Debt	95.32	50.9	50.57	53.17	46.02
Net Cash (Debt)	-42.57	-1.17	24.72	-11.78	37.9
Net Cash Growth	-	-	-	-	-45.99%
Net Cash Per Share	-0.89	-0.03	0.67	-0.34	1.09
Book Value	-84.48	-65.7	-1.84	-27.05	26.79
Book Value Per Share	-1.77	-1.39	-0.05	-0.78	0.77
Tangible Book Value	-84.49	-65.71	-1.85	-27.05	26.79
Tangible Book Value Per Share	-1.77	-1.39	-0.05	-0.78	0.77

SEC Filings: 10-K · 10-Q